|Day Low/High||258.82 / 262.56|
|52 Wk Low/High||151.85 / 268.00|
Newly confirmed cases of the Covid-19 virus spiked from Hubei Province in China, where the city of Wuhan is located. The number of related deaths increased as well.
Here in greater China, we are staying home and binge-watching dramas, ordering everything we can online. 'Parasite's' best-movie Oscar is a victory for Asia at a time it's looking for winners.
China-based Alibaba reports quarterly performance Thursday morning. While one might think that an e-commerce type operation could do well in a quarantined environment, it's not quite that easy.
The market's resilience in the face of such an ugly threat has many market players trying to find ways to reconcile the movement with the news flow.
According to an article from CNBC.com, more people are stuck at home in China as they wait out the coronavirus outbreak, giving some delivery and e-commerce companies an opportunity, even as they try to manage the risks of the disease. Of course my...
Hong Kong stocks surprisingly advanced a bit on Monday, but many stocks in mainland markets sold off by the 10% maximum.
Let's instead do the kind of security analysis you have to do if you are going to navigate this moment.
Here are two strategies to invest as UBER unloads its 'Eats' business in India, navigates California law and gets a lift by analysts.
Can we count on the recent uptrend to continue?
With 'FOMO' investors helping the Nasdaq surge towards 9,000 in recent weeks, it might not take a lot of bad news for tech stocks to correct in early 2020.
RBC analysts expect Alibaba and Salesforce to continue posting strong double-digit sales growth, and remain fans of Constellation's M&A-driven growth strategy.
There are two overt threats to market health and by extension to U.S. economic growth.
And we could be in the middle of the perfect storm for oil markets, where prices can rise aggressively through the first quarter.
Plus, the Saudis look to press their oil agenda while Europe prints some ugly economic data.
Write this city off at your peril. Hong Kong is still the financial capital of East Asia, and will remain so as long as the Chinese Communist Party refuses to ease its capital controls.
Though there are legitimate concerns about Uber's business that the company still needs to address, it's worth recalling how negative investors once were towards some tech giants at far lower levels.
The Hong Kong stock market rallied for no good reason on Monday and Tuesday, then surrendered those gains; meanwhile, Alibaba easily sold $11 billion in stock there.
At a time when many quality tech companies are staring at huge 2019 gains, spotting good deals takes a bit of effort. But it's by no means impossible.
The police in Hong Kong are being encouraged to crack down harder and harder on pro-democracy demonstrators that Beijing dubs "terrorists." Cracking down is not working.
Fresh off the excitement of Singles Day, JD is the stock that appears a better play right now, as it's finding niche spots to fill in logistics and housing.
Compared with prior Singles Day events, Alibaba got a bigger sales lift this year from 'lower-tier' Chinese cities, and saw stronger promotional activity from big brands.
Are we going to see an arbitrage begin to play out between the cross-border exchanges?
The Chinese e-commerce giant crushes even Amazon Prime Day, but it still needs some political wins to get where it wants to go; here's how to play the stock now.
China honors November 11 with an e-commerce extravaganza due to set one-day sales records. However, China's stock markets take a hit due to Hong Kong 'hitch.'
Whether there will be a breakout in the online retailer's shares remains to be seen.
While U.S. and Chinese firms are trying to fully disengage with each other, many are trying to guarantee that they have options should economic tensions worsen.
Hong Kong has its first firmly protest-related death, after a second-year university student died from a car park fall. Conspiracies fly in this city of demonstration, once again likely to burn aflame.
As for pressure on the Chinese side, I think a September 17.8% decline in exports to the U.S. compounded on top of a 22% decline in August speaks for itself.
The nation enters an electoral season. The drug companies for the most part, have no friends on either side of the aisle.
There is no way we don't have some sort of trade deal signed out of Chile.